ImmunoGen Allows Vertex Pharma Use Its Technology For Conditioning Agents For Use With Gene Editing
March 01, 2023 at 11:27 AM EST
ImmunoGen Inc(NASDAQ: IMGN) announced a global, multi-targetlicense and option agreementthat grantedVertex ...